면역치료제 시장은 2021년 1,863억 2천만 달러에서 성장할 것으로 예상됩니다. 2031년까지 미화 4,760억 4천만 달러; 2022년부터 2031년까지 CAGR 14.4%로 성장할 것으로 예상됩니다.
단클론 항체에 대한 수요 증가는 면역치료제 시장. 면역요법에 사용되는 단일클론 항체는 세포 클론에서 인공적으로 생성되므로 단일 유형의 면역글로불린으로 구성됩니다. 그들은 특정 항원을 표적으로 삼고 항원과 결합하여 복합체를 형성합니다. 단일클론항체는 암, 류마티스 관절염, 다발성 경화증, 전신홍반루푸스, 심혈관 질환 등의 질병을 치료하는 데 사용될 수 있습니다. 식품의약국(FDA)에 따르면 2021년까지 450개 이상의 단일클론 항체가 승인되었습니다. 2022년 2월, FDA는 새로운 벳텔로비맙에 대한 긴급 사용 승인(EUA)을 발표했습니다. 단클론 항체는 SARS-CoV-2의 오미크론 변종에 효과적입니다. . 이 약물은 경증~중등도 증상을 보이는 성인 및 소아 환자 또는 중증 코로나19로 진행될 위험이 높은 환자에게 효과적이었습니다.
시장 역학
면역치료제 시장의 성장은 주로 표적 질환에 대한 수요 증가, 바이오시밀러 및 단일클론항체에 대한 수요 증가, 기존 치료법에 비해 면역치료제 카테고리 채택 증가에 기인합니다. 그러나 면역치료제 제조와 관련된 과제로 인해 시장 성장이 저해되고 있습니다. 더욱이, 맞춤형 의학적 치료법에 대한 수요 증가로 인해 예측 기간 동안 면역요법 약물 시장의 성장이 촉진되고 있습니다.
전략적 통찰력
시장 범위
&ldquo ;2031년까지의 글로벌 면역치료제 시장 분석” 보고서는 유형, 임상 적응증 및 최종 사용자를 기준으로 상세한 시장 세분화를 통해 면역치료제 시장에 대한 개요를 제공하는 것을 목표로 합니다. 이 보고서는 주요 플레이어의 성과를 기반으로 주요 시장 통계를 제공합니다. 또한 시장의 주요 트렌드와 기회를 제공합니다.
시장 세분화
글로벌 면역치료제 시장은 다음과 같이 분류됩니다. , 임상 적응증 및 최종 사용자. 유형에 따라 시장은 백신 보조제, 수지상 세포 활성제 및 앰프로 분류됩니다. 성장 인자, T 세포 자극제 & 성장 인자, 면역 체크포인트 억제제, 단클론 항체, 인터루킨 & 인터페론 및 기타. 적응증에 따라 시장은 암, 염증성 질환, 자가면역 질환, 전염병 등으로 분류됩니다. 최종 사용자 부문은 병원 & 진료소, 외래 수술 센터 및 기타.
글로벌 면역치료제 시장은 북미, 유럽, 아시아 태평양, 중동의 5개 주요 지역으로 분류됩니다. & 아프리카, 남부 & 중앙 아메리카. 이 보고서는 전 세계 18개국에 대한 분석 및 예측과 함께 해당 지역지역에 만연한 동향 및 기회를 다룹니다.
지역적 관점에서 볼 때 북미는 2021년 최대 40%의 시장 점유율로 면역치료제 시장을 지배합니다. 이 지역의 시장 성장은 주로 다음에 기인합니다. F. Hoffmann-La Roche Ltd., Pfizer Inc., Merck & 공동, Novartis International AG, Johnson & 존슨, 사노피, 글락소스미스클라인 PLC. 아래 그림은 북미 면역치료제 시장의 매출 성장 추세를 보여줍니다.
< span style="font-family: verdana, geneva, sans-serif; 글꼴 크기: 10pt;">출처: The Insight Partners Analysis
코로나19 팬데믹의 영향
코로나19 사태로 면역항암제 수요가 늘어나면서 제약사들의 주문량이 늘어나 생산량도 늘어났다. 생산량의 증가로 인해 다양한 의약품 구성 요소 제조업체의 제품 이익이 증가했습니다. 이에 따라 SARS-CoV-2 확산 초기에 의약품 성분 조달이 늘어나 글로벌 면역치료제 시장의 성장이 가속화됐다.
대부분의 수요는 백신 보조제 제조업체. 미국 식품의약국(FDA)은 화이자/바이오엔테크(Pfizer/BioNTech) 및 모더나(Moderna) 코로나19 백신에 대한 긴급 사용 승인을 승인했습니다. 이 약품은 의료 전문가가 16세 이상의 사람들에게 권장하는 것으로, 비용은 미화 19.50이며 30μg(0.3m) 용량입니다. 결과적으로 의약품 조달이 증가하여 예측 기간 동안 면역치료제 시장이 강화될 것입니다.
보고서에는 주요 면역치료제 프로필도 포함되어 있습니다. SWOT 분석 및 시장 전략과 함께 시장 회사. 또한 이 보고서는 회사 프로필, 제공되는 구성 요소 및 서비스, 지난 3년간의 재무 정보, 지난 5년간의 주요 개발과 같은 정보를 제공하는 업계 선두 기업에 중점을 두고 있습니다. 면역치료제 시장에 참여하는 몇몇 회사 목록은 다음과 같습니다.
- •Incyte Corporation•Juno Therapeutics•< span style="font-family: verdana, geneva, sans-serif; 글꼴 크기: 10pt;">Celldex Therapeutics•Tesaro, Inc.•F. Hoffmann-La Roche Ltd •Amgen Inc.•Novartis AG•BioNTech SE•Sanofi•GlaxoSmithKline Plc•화이자 주식회사< /span>•Merck & 공동•Johnson & Johnson
Insight Partner의 전담 연구 및 분석 팀은 경험이 풍부한 전문가들로 구성되어 있습니다. 고급 통계 전문 지식을 갖추고 있으며 기존 연구에서 다양한 사용자 정의 옵션을 제공합니다.
< img 스타일="디스플레이: 블록; 여백-왼쪽: 자동; 여백-오른쪽: 자동;" src="https://www.theinsightpartners.com/assets/rdimages/immunotherapy-drugs-market-img2.png" alt="시장 조사" width="350" height="350">
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Industrial Valves Market
- Long Read Sequencing Market
- Dealer Management System Market
- Adaptive Traffic Control System Market
- Hydrogen Compressors Market
- Legal Case Management Software Market
- Batter and Breader Premixes Market
- Latent TB Detection Market
- Thermal Energy Storage Market
- Clear Aligners Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Immunotherapy Drugs Market is expected to grow at a CAGR of 15.5% between 2023-2031
The driving factors impacting the Immunotherapy Drugs Market are: Rising Cancer Prevalence, Advancements in Immunotherapy Research
The future trends of the Immunotherapy Drugs Market are: Personalized Immunotherapy, Combination Therapies
The leading players in the Immunotherapy Drugs Market are: Incyte Corporation, Juno Therapeutics, Celldex Therapeutics Tesaro, Inc., F. Hoffmann-La Roche Ltd , Amgen Inc., Novartis AG, BioNTech SE, Sanofi, GlaxoSmithKline Plc, Pfizer Inc., Merck & Co, Johnson & Johnson
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Eli Lilly and Company
2. Astrazeneca
3. Abbvie
4. Amgen inc
5. GlaxoSmithKline Plc
6. Novartis International AG
7. Merck and Co., Inc
8. F. Hoffmann-La Roche AG
9. Bristol-Myers Squibb
10. UbiVac
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.